| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.46▼ | 1.46▼ | 1.46▼ | 1.45▼ | 1.53▼ |
| MA10 | 1.49▼ | 1.49▼ | 1.50▼ | 1.49▼ | 1.62▼ |
| MA20 | 1.52▼ | 1.52▼ | 1.52▼ | 1.52▼ | 1.50▼ |
| MA50 | 1.57▼ | 1.60▼ | 1.61▼ | 1.62▼ | 2.51▼ |
| MA100 | 1.63▼ | 1.60▼ | 1.57▼ | 1.49▼ | 4.30▼ |
| MA200 | 1.53▼ | 1.49▼ | 1.58▼ | 2.09▼ | 3.39▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.009▼ | -0.008▼ | -0.008▼ | -0.011▼ | 0.082▲ |
| RSI | 38.730▼ | 39.230▼ | 39.529▼ | 40.789▼ | 37.165▼ |
| STOCH | 19.511▼ | 17.911▼ | 17.911▼ | 25.412 | 35.842 |
| WILL %R | -86.667▼ | -88.889▼ | -88.889▼ | -70.833 | -68.182 |
| CCI | -130.667▼ | -120.628▼ | -120.628▼ | -152.961▼ | -69.560 |
|
Thursday, August 13, 2026 05:15 AM
Pulmatrix, Inc. ("Pulmatrix" or the "Company") (Nasdaq: PULM), a biopharmaceutical company that has focused on the development of novel inhaled therapeutic products intended to prevent and treat ...
|
|
Thursday, October 16, 2025 05:05 AM
FRAMINGHAM, Mass., Oct. 16, 2025 /PRNewswire/ -- Pulmatrix, Inc. ("Pulmatrix" or the "Company") (Nasdaq: PULM), a biopharmaceutical company that has focused on the development of novel inhaled ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 04/09/26 | 1.41 | 1.43 | 1.41 | 1.43 | 15,898 |
| 03/09/26 | 1.44 | 1.46 | 1.36 | 1.36 | 20,347 |
| 02/09/26 | 1.59 | 1.59 | 1.43 | 1.47 | 18,389 |
| 01/09/26 | 1.525 | 1.525 | 1.525 | 1.525 | 879 |
| 31/08/26 | 1.45 | 1.485 | 1.45 | 1.47 | 2,553 |
| 28/08/26 | 1.49 | 1.51 | 1.4584 | 1.51 | 3,301 |
| 27/08/26 | 1.50 | 1.60 | 1.4669 | 1.52 | 13,743 |
| 26/08/26 | 1.56 | 1.56 | 1.525 | 1.525 | 5,272 |
| 25/08/26 | 1.49 | 1.60 | 1.49 | 1.60 | 12,184 |
| 24/08/26 | 1.55 | 1.56 | 1.53 | 1.54 | 16,639 |
|
|
||||
|
|
||||
|
|